Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on mRNA Cap Analog. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112661802B reveals a scalable, non-toxic route for 3'-methoxyguanosine, offering significant cost reduction and supply chain reliability for mRNA cap analog manufacturing.